GlassScriptPhysician profile
Elizabeth M Leimer
NPI 1225598329
$1,914.16
in general payments reported to CMS, 2019-2025
8 companies · $706 in 2025
The $706 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,208 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012 · Travel and Lodging: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.55 |
| Travel and Lodging | $902.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,298.51 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Globus Medical, INC. | $125.88 | 2025 | Senza |
| Tersera Therapeutics LLC | $125.63 | 2025 | Prialt |
| Nalu Medical, INC. | $122.00 | 2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $93.70 | 2024 | |
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $54.18 | 2025 | |
| Si-Bone, INC. | $17.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Leimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.